TYSON & ASSOCIATES L-CARNITINE EDUCATIONAL MATERIAL DISCONTINUED
This article was originally published in The Tan Sheet
Executive Summary
TYSON & ASSOCIATES L-CARNITINE EDUCATIONAL MATERIAL DISCONTINUED following a December 1993 warning letter from FDA, the company's outside counsel told the agency Jan. 4. Responding to FDA charges that literature published and distributed by Tyson & Associates subsidiary Aatron Medical Services constituted "labeling" and made "violative" drug claims for the amino acid product, Tyson & Associates said that it has since "pulled all literature cited and discarded the information."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: